6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics
Recruiting now · Not applicable
Conditions studied: Type 2 Diabetes
In brief
To conduct a randomized control trial to determine the impact of 6-weeks of blood flow restriction training on immune cell function and bioenergetics in adults living with type 2 diabetes.
Key facts
- Study ID
- NCT07676305
- Run by
- University of British Columbia
- People needed
- 20
- Starts
- 2026-02-11
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-06-30
Who can join
Age: 19 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A. Aged 19-64 years. B. Diagnosed with type 2 diabetes with current HbA1c 5.7-9.0% C. Completing <150 minutes of moderate-vigorous physical activity per week.
You may not qualify if…
- A. Chronic musculoskeletal condition or recent (within 2 years) cardiovascular event preventing participation in exercise.
- B. Unstable type 2 diabetes medication of the last 3 months C. Absolute contraindications to BFR (i.e., peripheral vascular disease) D. A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions E. A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis) F. Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely G. Currently prescribed any medication which would impact the ability to use a heart rate monitor to accurately track intensity
Where it is running
- University of British Columbia Okanagan — Kelowna, British Columbia, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.